Stephen Sabba

Track

Insider profile

Currently holds a position at Ligand Pharmaceuticals Incorporated

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Ligand Pharmaceuticals Incorporated Aug. 4, 2008 -
Independent Director Novelion Therapeutics Inc June 4, 2012 - Dec. 31, 2019
Stephen Sabba's trades of Ligand Pharmaceuticals Incorporated's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-16
S Sale
34,968 +25.6%
69.35
US$2,078,323 		34,968 +25.6% 69.35 US$2,078,323
2026-06-16 2026-06-16
PrS Proposed sale
79,130
307.04
US$4,280,064 		79,130 307.04 US$4,280,064
2026-03-25 2026-03-23
S Sale
78,623 -49.0%
274.15
US$1,202,516 		78,623 -49.0% 274.15 US$1,202,516
2026-03-23 2026-03-23
PrS Proposed sale
1,000
207.87
US$207,873 		1,000 207.87 US$207,873
2026-03-05 2026-03-03
S Sale
2,034 -5.7%
201.50
US$409,851 		2,034 -5.7% 201.50 US$409,851
2026-03-03 2026-03-03
PrS Proposed sale
2,034
201.50
US$409,851 		2,034 201.50 US$409,851
2025-03-18 2025-03-18
PrS Proposed sale
2,406
106.00
US$255,036 		2,406 106.00 US$255,036
2024-03-07 2024-03-05
S Sale
1,893 -6.1%
74.30
US$140,650 		1,893 -6.1% 74.30 US$140,650
2024-03-05 2024-03-05
PrS Proposed sale
1,893
74.30
US$140,650 		1,893 74.30 US$140,650
2023-05-12 2023-05-10
S Sale
6,408 -19.9%
77.13
US$494,225 		6,408 -19.9% 77.13 US$494,225
2023-05-10 2023-05-10
PrS Proposed sale
6,408
77.13
US$494,225 		6,408 77.13 US$494,225
2021-02-11 2021-02-09
S Sale
14,114 -36.6%
208.55
US$2,943,475 		14,114 -36.6% 208.55 US$2,943,475
2021-02-11 2021-02-09
S Sale
556 -1.4%
208.00
US$115,648 		556 -1.4% 208.00 US$115,648